A detailed history of Hantz Financial Services, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 17,961 shares of LLY stock, worth $14.3 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
17,961
Previous 17,806 0.87%
Holding current value
$14.3 Million
Previous $16.1 Million 1.3%
% of portfolio
0.28%
Previous 0.31%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $119,681 - $148,803
155 Added 0.87%
17,961 $15.9 Million
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $12.9 Million - $16.2 Million
17,806 New
17,806 $16.1 Million
Q1 2024

Aug 06, 2024

BUY
$592.2 - $792.28 $332,224 - $444,469
561 Added 3.11%
18,582 $14.5 Million
Q4 2023

Aug 06, 2024

SELL
$525.19 - $619.13 $194,320 - $229,078
-370 Reduced 2.01%
18,021 $10.5 Million
Q3 2023

Aug 06, 2024

BUY
$434.7 - $599.3 $3.8 Million - $5.24 Million
8,741 Added 90.58%
18,391 $9.88 Million
Q2 2023

Aug 06, 2024

BUY
$350.74 - $468.98 $93,647 - $125,217
267 Added 2.85%
9,650 $4.53 Million
Q1 2023

Aug 06, 2024

BUY
$310.63 - $364.82 $715,070 - $839,815
2,302 Added 32.51%
9,383 $3.22 Million
Q4 2022

Aug 06, 2024

BUY
$321.55 - $374.67 $220,261 - $256,648
685 Added 10.71%
7,081 $2.59 Million
Q3 2022

Aug 06, 2024

BUY
$296.48 - $337.87 $109,697 - $125,011
370 Added 6.14%
6,396 $2.07 Million
Q2 2022

Aug 06, 2024

BUY
$278.73 - $327.27 $236,084 - $277,197
847 Added 16.35%
6,026 $1.95 Million
Q1 2022

Aug 06, 2024

SELL
$234.69 - $291.66 $2.96 Million - $3.68 Million
-12,627 Reduced 70.91%
5,179 $1.48 Million
Q3 2020

Aug 06, 2024

SELL
$146.22 - $169.13 $2.57 Million - $2.98 Million
-17,600 Reduced 98.84%
206 $30,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.